BURE Stock Analysis: Bure Equity | ST
Asset Management | ST, Sweden | Market Cap: 19.862m SEK | 12M Return: -7.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 25.6M
Rev. Trend: 83.8%
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Bure Equity AB (publ) is a Stockholm-based private equity and venture capital firm founded in 1992. The firm is structured as a publicly listed Swedish investment company (investmentbolag), one of a small group of Nordic-listed PE/venture vehicles that trade on Nasdaq Stockholm and provide public market investors with exposure to private equity returns.
The firm pursues a broad investment strategy spanning buyouts, growth capital, secondary direct, later-stage, and special situations such as turnarounds and recapitalizations. It seeks majority, controlling stakes and typically acts as principal shareholder in its portfolio companies.
Sector focus is diversified across education services, telecommunications, medtech, healthcare, consumer staples, financials, industrials, and information technology. Geographically, the firm concentrates on the Nordics and other European developed markets, with equity tickets generally ranging from $5 million to $100 million per transaction.
- Medtech and education portfolio holdings drive NAV higher
- Realization activity lifts dividend and buyback capacity
- Nordic equity rally narrows discount to NAV
| Net Income: -3.82b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA 0.86 > 1.0 |
| NWC/Revenue: 148.3% < 20% (prev 315.2%; Δ -166.8% < -1%) |
| CFO/TA 0.03 > 3% & CFO 554.0m > Net Income -3.82b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.40 > 1.5 & < 3 |
| Outstanding Shares: last quarter (74.2m) vs 12m ago -0.41% < -2% |
| Gross Margin: 80.67% > 18% (prev 71.31%; Δ 9.36% > 0.5%) |
| Asset Turnover: 1.19% > 50% (prev 1.10%; Δ 0.08% > 0%) |
| Interest Coverage Ratio: -1.75 > 6 (EBIT TTM -3.82b / Interest Expense TTM 2.19b) |
| A: 0.02 (Total Current Assets 605.0m - Total Current Liabilities 252.0m) / Total Assets 18.1b |
| B: 0.88 (Retained Earnings 15.9b / Total Assets 18.1b) |
| C: -0.19 (EBIT TTM -3.82b / Avg Total Assets 20.1b) |
| D: 949.4 (Book Value of Equity 18.0b / Total Liabilities 19.0m) |
| Altman-Z'' = 998.5 = AAA |
| DSRI: 1.66 (Receivables 84.0m/52.0m, Revenue 238.0m/244.0m) |
| GMI: 0.88 (GM 71.31% / 80.67%) |
| AQI: 1.00 (AQ_t 0.97 / AQ_t-1 0.96) |
| SGI: 0.98 (Revenue 238.0m / 244.0m) |
| TATA: -0.24 (NI -3.82b - CFO 554.0m) / TA 18.1b) |
| Beneish M = -2.63 (Cap -4..+1) = A |
As of July 07, 2026, the stock is trading at SEK 264.60 with a total of 53,616 shares traded. Over the past week, the price has changed by +2.00%, over one month by -3.08%, over three months by +22.96% and over the past year by -7.88%.
Current recommended Stop Loss: 253.50 (which is 4.2% or 1.4 ATR below the current price).
Bure Equity has no consensus analysts rating.
P/E Forward = 10.5152
P/S = 111.2203
P/B = 1.0812
P/EG = 1.1592
Revenue TTM = 238.0m SEK
EBIT TTM = -3.82b SEK
EBITDA TTM = -3.81b SEK
Long Term Debt = 1.00m SEK (from longTermDebtTotal, last fiscal year)
Short Term Debt = 2.00m SEK (from shortTermDebt, last quarter)
Debt = 3.00m SEK (from shortLongTermDebtTotal, last quarter) (leases 3.00m already included)
Net Debt = -518.0m SEK (calculated: Debt 3.00m - CCE 521.0m)
Enterprise Value = 19.3b SEK (19.9b + Debt 3.00m - CCE 521.0m)
Interest Coverage Ratio = -1.75 (Ebit TTM -3.82b / Interest Expense TTM 2.19b)
EV/FCF = 66.02x (Enterprise Value 19.3b / FCF TTM 293.0m)
FCF Yield = 1.51% (FCF TTM 293.0m / Enterprise Value 19.3b)
FCF Margin = 123.1% (FCF TTM 293.0m / Revenue TTM 238.0m)
Net Margin = -1.61k% (Net Income TTM -3.82b / Revenue TTM 238.0m)
Gross Margin = 80.67% ((Revenue TTM 238.0m - Cost of Revenue TTM 46.0m) / Revenue TTM)
Gross Margin QoQ = 67.74% (prev -30.0%)
Tobins Q-Ratio = 1.07 (Enterprise Value 19.3b / Total Assets 18.1b)
Interest Expense / Debt = 72.9k% (Interest Expense 2.19b / Debt 3.00m)
Taxrate = 25.0% (non-US conservative default 25%)
NOPAT = -2.86b (EBIT -3.82b * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 2.40 (Total Current Assets 605.0m / Total Current Liabilities 252.0m)
Debt / Equity = 0.00 (Debt 3.00m / totalStockholderEquity, last quarter 18.0b)
Debt / EBITDA = 0.14 (negative EBITDA) (Net Debt -518.0m / EBITDA -3.81b)
Debt / FCF = -1.77 (Net Debt -518.0m / FCF TTM 293.0m)
Total Stockholder Equity = 19.7b (last 4 quarters mean from totalStockholderEquity)
RoA = -19.03% (Net Income -3.82b / Total Assets 18.1b)
RoE = -19.39% (Net Income TTM -3.82b / Total Stockholder Equity 19.7b)
RoCE = -19.37% (EBIT -3.82b / Capital Employed (Equity 19.7b + L.T.Debt 1.00m))
RoIC = -15.86% (negative operating profit) (NOPAT -2.86b / Invested Capital 18.1b)
WACC = 9.30% (E(19.9b)/V(19.9b) * Re(9.30%) + (debt cost/tax rate unavailable))
Discount Rate = 9.30% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -9.43 | Cagr: -0.07%
[DCF] Terminal Value 74.96% ; FCFF base≈243.4m ; Y1≈279.0m ; Y5≈410.6m
[DCF] Fair Price = 78.35 (EV 5.29b - Net Debt -518.0m = Equity 5.81b / Shares 74.2m; r=9.30% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 83.76 | Revenue CAGR: 11.76% | SUE: N/A | # QB: 0